These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33052524)
1. Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Shin S; Nam HY; Lee MJ; Pak K; Kim K; Kim IJ Ann Nucl Med; 2021 Jan; 35(1):76-82. PubMed ID: 33052524 [TBL] [Abstract][Full Text] [Related]
2. Age and gender effects on striatal dopamine transporter density and cerebral perfusion in individuals with non-degenerative parkinsonism: a dual-phase Kim JY; Kang SY; Moon BS; Kim BS; Jeong JH; Yoon HJ EJNMMI Res; 2024 Jul; 14(1):65. PubMed ID: 39017925 [TBL] [Abstract][Full Text] [Related]
3. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects. Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380 [TBL] [Abstract][Full Text] [Related]
4. Age-related effects and gender differences in Japanese healthy controls for [ Yamamoto H; Arimura S; Nakanishi A; Shimo Y; Motoi Y; Ishiguro K; Murakami K; Hattori N; Aoki S Ann Nucl Med; 2017 Jun; 31(5):407-412. PubMed ID: 28382589 [TBL] [Abstract][Full Text] [Related]
5. Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects. Pak K; Shin S; Kim SJ; Kim K; Kim BS; Kim SJ; Kim IJ Sci Rep; 2017 Oct; 7(1):13261. PubMed ID: 29038492 [TBL] [Abstract][Full Text] [Related]
6. Effects of rs591323 on serotonin transporter availability in healthy male subjects. Pak K; Nam HY; Shin S; Kim K; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ Ann Nucl Med; 2018 Aug; 32(7):431-436. PubMed ID: 29774458 [TBL] [Abstract][Full Text] [Related]
7. Voxel-based analysis of age and gender effects on striatal [ Shigemoto Y; Matsuda H; Kimura Y; Chiba E; Ohnishi M; Nakaya M; Maikusa N; Ogawa M; Mukai Y; Takahashi Y; Sako K; Toyama H; Inui Y; Taki Y; Nagayama H; Ono K; Kono A; Sekiguchi K; Hirano S; Sato N Ann Nucl Med; 2022 May; 36(5):460-467. PubMed ID: 35174441 [TBL] [Abstract][Full Text] [Related]
8. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Knudsen GM; Koulibaly PM; Nobili F; Pagani M; Sabri O; Vander Borght T; Van Laere K; Tatsch K Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):213-27. PubMed ID: 23160999 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters. Nam SB; Kim K; Kim BS; Im HJ; Lee SH; Kim SJ; Kim IJ; Pak K Sci Rep; 2018 Mar; 8(1):4924. PubMed ID: 29563547 [TBL] [Abstract][Full Text] [Related]
10. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993 [TBL] [Abstract][Full Text] [Related]
11. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease. Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292 [TBL] [Abstract][Full Text] [Related]
12. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712 [TBL] [Abstract][Full Text] [Related]
14. Effect of white matter hyperintensity on dopamine transporter availability of striatum measured by F-18 FP-CIT PET. Shin S; Jun S; Nam HY Jpn J Radiol; 2021 Nov; 39(11):1097-1102. PubMed ID: 34142306 [TBL] [Abstract][Full Text] [Related]
15. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365 [TBL] [Abstract][Full Text] [Related]
16. [Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone]. Mateos JJ; Lomeña F; Parellada E; Font M; Fernández E; Pavia J; Prats A; Bernardo M Rev Esp Med Nucl; 2006; 25(3):159-65. PubMed ID: 16762269 [TBL] [Abstract][Full Text] [Related]
17. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation. Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495 [TBL] [Abstract][Full Text] [Related]
18. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A Pettorruso M; Martinotti G; Cocciolillo F; De Risio L; Cinquino A; Di Nicola M; Camardese G; Migliara G; Moccia L; Conte E; Janiri L; Di Giuda D Addict Biol; 2019 Sep; 24(5):1077-1086. PubMed ID: 30226290 [TBL] [Abstract][Full Text] [Related]
19. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings. Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996 [TBL] [Abstract][Full Text] [Related]
20. No effect of Parkinson's disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects. Pak K; Lee MJ; Kim K; Kim IJ Ann Nucl Med; 2021 Nov; 35(11):1187-1192. PubMed ID: 34287783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]